Paper53655
Bromocriptine therapy in acromegaly.
Sachdev Y and 6 others. Lancet, 1975. Cited by 117 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bromocriptine therapy in acromegaly. Papers, record 53655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53655
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acromegaly | Major topic |
| Bromocriptine | Major topic |
| Ergolines | Major topic |
| 11-Hydroxycorticosteroids | |
| Administration, Oral | |
| Adult | |
| Aged | |
| Blood Glucose | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Female | |
| Follicle Stimulating Hormone | |
| Growth Hormone | |
| Humans | |
| Luteinizing Hormone | |
| Male | |
| Middle Aged | |
| Pituitary Function Tests | |
| Thyrotropin | |
| Thyrotropin-Releasing Hormone | |
| Time Factors |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,616,105 | Understanding the role of dopamine in cancer: past, present and future. | Carcinogenesis | 2022 | https://conductscience.org/library/papers/35616105 | PubMed |
| 29,907,594 | Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer. | Mol Cancer Ther | 2018 | https://conductscience.org/library/papers/29907594 | PubMed |
| 12,812,311 | Current status and future opportunities for controlling acromegaly. | Pituitary | 2002 | https://conductscience.org/library/papers/12812311 | PubMed |
| 7,514,973 | Acromegaly. Recognition and treatment. | Drugs | 1994 | https://conductscience.org/library/papers/7514973 | PubMed |
| 7,427,100 | Bromocriptine as sole treatment for acromegaly. | Br Med J | 1980 | https://conductscience.org/library/papers/7427100 | PubMed |
| 7,410,043 | Pregnancy in an acromegalic after bromocriptine therapy. | Ir J Med Sci | 1980 | https://conductscience.org/library/papers/7410043 | PubMed |
| 7,204,884 | The effect of tamoxifen on GH and PRL secretion by human pituitary tumors. | J Endocrinol Invest | 1980 | https://conductscience.org/library/papers/7204884 | PubMed |
| 7,027,229 | Bromocriptine therapy in acromegaly. A long-term review of 35 cases. | Postgrad Med J | 1981 | https://conductscience.org/library/papers/7027229 | PubMed |
| 6,993,548 | Bromocriptine acute effect on insulin, glucagon and growth hormone levels in acromegalic patients. | J Endocrinol Invest | 1980 | https://conductscience.org/library/papers/6993548 | PubMed |
| 6,782,153 | Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states. | J Endocrinol Invest | 1980 | https://conductscience.org/library/papers/6782153 | PubMed |
| 6,140,273 | Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6140273 | PubMed |
| 6,138,432 | Recent developments in acromegaly: a review. | J R Soc Med | 1983 | https://conductscience.org/library/papers/6138432 | PubMed |
| 2,046,904 | Reduction in sella turcica volume. An effect of long-term treatment with the somatostatin analogue, SMS 201-995, in acromegalic patients. | Neuroradiology | 1991 | https://conductscience.org/library/papers/2046904 | PubMed |
| 1,276,803 | Coagulation studies in patients treated with bromocriptine. | Br Med J | 1976 | https://conductscience.org/library/papers/1276803 | PubMed |
| 653,899 | Prediction of response to bromocriptine in acromegaly. | Ulster Med J | 1978 | https://conductscience.org/library/papers/653899 | PubMed |
| 650,205 | Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine. | J Neural Transm | 1978 | https://conductscience.org/library/papers/650205 | PubMed |
| 577,473 | Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment. | Br Med J | 1977 | https://conductscience.org/library/papers/577473 | PubMed |
| 576,843 | Long-term treatment of acromegaly with bromocriptine. | Br Med J | 1977 | https://conductscience.org/library/papers/576843 | PubMed |
| 576,842 | Bromocriptine--fact or expensive fancy. | Br Med J | 1977 | https://conductscience.org/library/papers/576842 | PubMed |
| 489,916 | Effect of bromocriptine administration on gastric acid and gastrin secretion in man. | J Endocrinol Invest | 1979 | https://conductscience.org/library/papers/489916 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GH1 | 2,688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| PRL | 5,617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/53655
GET https://conductscience.org/api/papers/v1/53655/cited_by?page=2